The Latest Research in Overactive Bladder : Abstracts + "Beyond the Abstracts"

Recent Abstracts

Overactive Bladder

April 27, 2025

Expert Opinions on Best Practices for Overactive Bladder Management with onabotulinumtoxinA.
Overactive Bladder

April 27, 2025

A Prospective Study on the Effectiveness of Sensory and Sub-sensory Stimulation Amplitudes Using eCoin® Implantable Tibial Nerve Stimulation in Reducing Urgency Urinary Incontinence Episodes and Enhancing Quality of Life.
Overactive Bladder

April 27, 2025

Assessment of efficacy of mirabegron, solifenacin, tadalafil 5 mg and combination therapy in female patients with overactive bladder: a double blinded multicenter prospective placebo-controlled trial.
Overactive Bladder

April 27, 2025

Analyzing outcomes of the adjustable transobturator male system (ATOMS) for postprostatectomy incontinence and its relationship with detrusor overactivity and radiotherapy with the help of urodynamics.
Overactive Bladder

April 27, 2025

Complex carbohydrates catabolism capacity of bladder microbiota inhabiting healthy and overactive female bladders.
Overactive Bladder

April 27, 2025

Association of weight-adjusted waist index (WWI) with overactive bladder (OAB): a cross-sectional study from NHANES 2005-2018.
Overactive Bladder

April 20, 2025

Predictive role of neutrophil-percentage-albumin ratio (NPAR) in overactive bladder (OAB) in adults in the United States: a cross-sectional study.
Overactive Bladder

April 20, 2025

Long-term cost-effectiveness of invasive urodynamic studies for overactive bladder in women.
Overactive Bladder

April 11, 2025

Association between novel inflammatory markers and overactive bladder: a cross-sectional study of NHANES 2009 to 2018.
Overactive Bladder

April 11, 2025

Comparison of efficacy and safety of mirabegron and vibegron in the treatment of Overactive Bladder (OAB) in older women: A systematic review and meta-analysis.

View All (126 Pages)

Beyond the Abstracts

Overactive Bladder

March 10, 2025

Mirabegron versus Placebo and Other Therapeutic Modalities in the Treatment of Patients with Overactive Bladder Syndrome-A Systematic Review - Beyond the Abstract
Overactive Bladder

February 27, 2025

Antibiotic Therapy for Treating Overactive Bladder Is Not Supported by Clinical Evidence - Beyond the Abstract
Overactive Bladder

July 23, 2024

Oxybutynin-Associated Cognitive Impairment: Evidence and Implications for Overactive Bladder Treatment - Beyond the Abstract
Overactive Bladder

July 1, 2024

Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices - Beyond the Abstract
Overactive Bladder

February 7, 2024

Factors Influencing Medication Selection for Management of Overactive Bladder: Trends and Insights from AUA Quality Registry - Beyond the Abstract
Overactive Bladder

June 26, 2023

Intradetrusor OnabotulinumtoxinA Injections at the Time of Holmium Laser Enucleation of the Prostate for Men with Overactive Bladder Symptoms - Beyond the Abstract
Overactive Bladder

March 20, 2023

Budget Impact Analysis of Vibegron for the Treatment of Overactive Bladder in the USA - Beyond the Abstract
Overactive Bladder

February 22, 2023

The Choice of Therapeutic Agent in Female Overactive Bladder Patients in Real-World Practice - Beyond the Abstract
Overactive Bladder

January 17, 2023

Urobiome Changes Differ Based on OAB Treatment in Adult Females - Beyond the Abstract
Overactive Bladder

September 29, 2022

A Systematic Review and In Silico Study of Potential Genetic Markers Implicated in Cases of Overactive Bladder - Beyond the Abstract

View All (5 Pages)